Surgacoll
About Surgacoll
SurgaColl Technologies Ltd is a pioneer in the field of regenerative medicine. A spin out from the RCSI, the company is developing highly innovative tissue repair implants designed to enable cartilage and bone regeneration improving outcomes and standard of care for patients worldwide. SurgaColl has two products - HydroxyColl is a 'next generation' bone graft substitute and ChondroColl is a bio-mimetic three layer Cartilage repair implant.LEADERSHIP:
CEO: William (Bill) Allan
FOLLOW SURGACOLL:
Tweets by Surgacoll
2 articles about Surgacoll
-
SurgaColl Holdings Ltd Announces Series A Funding, Opens HQ in Alderley Park
1/10/2018
Surgacoll today announced the completion of its Series A funding, led by the GM&C Life Sciences Fund, and including investment from Julz Co, a US-based healthcare fund.
-
Surgacoll Taps Medtech Vet as New CEO
1/16/2017